New BD Assay Advances Immunology Research Capabilities of Multiomics
BD recently launched a set of reagents designed to enable researchers to more easily analyze important cells in the immune system.
Read MorePosted by Andy Lundin | Apr 21, 2022 | Immunoassay Reagents & test Kits |
BD recently launched a set of reagents designed to enable researchers to more easily analyze important cells in the immune system.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Covid 19 |
The research group tested nanotechnology-based optical sensors designed for COVID detection and saw the potential for their home-grown tech.
Read MorePosted by Chris Wolski | Apr 5, 2022 | Specimen Collection & Handling |
Dried blood spot testing provides clinical labs an easy-to-collect, reliable, and cost-effective means to test for a variety of diseases.
Read MorePosted by Andy Lundin | Mar 30, 2022 | Covid 19, Flu & Respiratory Infections |
Preliminary clinical study results for Lucira’s COVID-19 & Flu test demonstrated similar sensitivity and specificity to lab-based PCR assays.
Read MorePosted by Andy Lundin | Mar 29, 2022 | Covid 19, Flu & Respiratory Infections, Immunoassay Reagents & test Kits |
Visby Medical received $25.5 million in federal funding to develop and validate an at-home combination Flu-Covid test from BARDA.
Read More